Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 100.0 |
| Revenue growth | | | | | | -100.0% | 0.0% | 0.0% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 87.4 | 88.9 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.6 | 11.1 |
| Gross margin | | | | | | | 12.6% | 11.1% |
| Selling, general and administrative | | | | | | | 7.3 | 7.0 |
| Sales and marketing | 294,482.0 | 393,075.0 | 376,940.0 | 368,318.0 | 369,245.0 | 1,557,277.0 | | |
| EBIT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.3 | 4.1 |
| EBIT margin | | | | | | | 5.3% | 4.1% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | | | | | | | 0.0% | 0.0% |
| |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|